Early mRNA vaccine trial results show potential breakthrough in fighting one of the deadliest cancers
“The latest data from the Phase I trial are encouraging,” said the study’s lead author.
Tomas Kauer - Moderator 
“The latest data from the Phase I trial are encouraging,” said the study’s lead author. Read More
